Total Payments
$377,298
2024 Payments
$13,067
Companies
18
Transactions
287
Medicare Patients
9,719
Medicare Billing
$427,086
Payment Breakdown by Category
Consulting$289,833 (76.8%)
Research$51,717 (13.7%)
Other$27,950 (7.4%)
Travel$6,126 (1.6%)
Food & Beverage$1,653 (0.4%)
Education$18.84 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $289,833 | 216 | 76.8% |
| Unspecified | $51,717 | 31 | 13.7% |
| Honoraria | $25,450 | 7 | 6.7% |
| Travel and Lodging | $6,126 | 18 | 1.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,500 | 1 | 0.7% |
| Food and Beverage | $1,653 | 13 | 0.4% |
| Education | $18.84 | 1 | 0.0% |
Payments by Type
General
$325,581
256 transactions
Research
$51,717
31 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim b.v. | $88,000 | 13 | $0 (2018) |
| ABBVIE INC. | $85,977 | 108 | $0 (2024) |
| Boehringer Ingelheim International GmbH | $72,750 | 37 | $0 (2018) |
| PFIZER INC. | $35,244 | 56 | $0 (2024) |
| ABIOMED | $27,287 | 14 | $0 (2024) |
| BRACCO DIAGNOSTICS INC. | $22,417 | 8 | $0 (2018) |
| Quidel Corporation | $18,713 | 6 | $0 (2023) |
| Boehringer Ingelheim Pharma GmbH & Co.KG | $12,733 | 20 | $0 (2018) |
| BOSTON SCIENTIFIC CORPORATION | $4,010 | 5 | $0 (2018) |
| Ortho-Clinical Diagnostics, Inc. | $3,225 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,067 | 29 | ABBVIE INC. ($5,723) |
| 2023 | $76,423 | 42 | AbbVie Inc. ($35,322) |
| 2022 | $16,271 | 29 | ABBVIE INC. ($12,496) |
| 2021 | $11,937 | 23 | AbbVie Inc. ($7,542) |
| 2020 | $14,309 | 19 | AbbVie Inc. ($6,404) |
| 2019 | $21,964 | 26 | AbbVie, Inc. ($9,848) |
| 2018 | $109,308 | 63 | Boehringer Ingelheim International GmbH ($39,400) |
| 2017 | $114,021 | 56 | Boehringer Ingelheim b.v. ($65,750) |
All Payment Transactions
287 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $80.00 | General |
| 12/13/2024 | HEARTFLOW, INC. | FFRct (Device) | Travel and Lodging | Cash or cash equivalent | $452.95 | General |
| Category: Coronary | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Consulting Fee | Cash or cash equivalent | $892.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Consulting Fee | Cash or cash equivalent | $262.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Consulting Fee | Cash or cash equivalent | $105.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Travel and Lodging | In-kind items and services | $205.10 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/06/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $31.91 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/06/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/06/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/05/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Travel and Lodging | In-kind items and services | $249.32 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/05/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $156.93 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/05/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Travel and Lodging | In-kind items and services | $127.91 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Travel and Lodging | In-kind items and services | $487.63 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/16/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| 10/16/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $425.00 | General |
| 08/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Consulting Fee | Cash or cash equivalent | $1,680.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $174.97 | General |
| Category: Transcatheter Heart Valves | ||||||
| 08/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Consulting Fee | Cash or cash equivalent | $630.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Consulting Fee | Cash or cash equivalent | $577.50 | General |
| Category: IMMUNOLOGY | ||||||
| 07/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Consulting Fee | Cash or cash equivalent | $262.50 | General |
| Category: IMMUNOLOGY | ||||||
| 05/01/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $145.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/01/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $125.00 | General |
| 04/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $182.80 | General |
| 03/14/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $385.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress Echocardiography with Dobutamine for the Diagnosis of Coronary Artery Disease | BRACCO DIAGNOSTICS INC. | $20,398 | 2 |
| CS-0908-01-High Note | Quidel Corporation | $18,713 | 6 |
| M13-545 | AbbVie, Inc. | $4,800 | 12 |
| TriageTrue high sensitivity Troponin | Ortho-Clinical Diagnostics, Inc. | $3,225 | 1 |
| M13-538 | AbbVie, Inc. | $1,388 | 2 |
| M19-130 | AbbVie Inc. | $900.00 | 1 |
| A Phase 2 Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination (ABBV-599 Combination) in Subjects with Moderately to Severely Active Systemic Lupus Erythematosus | ABBVIE INC. | $688.50 | 3 |
| A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) | ABBVIE INC. | $210.00 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 852 | 961 | $197,837 | $34,516 |
| 2022 | 19 | 2,782 | 3,347 | $588,310 | $108,690 |
| 2021 | 18 | 3,015 | 3,555 | $686,644 | $135,496 |
| 2020 | 16 | 3,070 | 3,714 | $752,559 | $148,384 |
Total Patients
9,719
Total Services
11,577
Medicare Billing
$427,086
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 132 | 136 | $73,455 | $11,947 | 16.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 161 | 161 | $46,046 | $8,371 | 18.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 72 | $20,880 | $4,823 | 23.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 53 | 53 | $23,750 | $3,418 | 14.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 273 | 327 | $11,118 | $2,028 | 18.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $7,993 | $1,373 | 17.2% |
| 93314 | Interpretation and report of ultrasound of heart | Facility | 2023 | 14 | 14 | $5,544 | $1,045 | 18.9% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 19 | 19 | $1,957 | $376.38 | 19.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 70 | 71 | $2,414 | $367.07 | 15.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 28 | 30 | $2,557 | $339.82 | 13.3% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 15 | 15 | $1,095 | $223.95 | 20.5% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 20 | 20 | $580.00 | $119.80 | 20.7% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 32 | 32 | $448.00 | $82.56 | 18.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 91 | 253 | $103,556 | $22,034 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 202 | 233 | $124,114 | $20,196 | 16.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 346 | 349 | $103,580 | $19,007 | 18.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 1,355 | 1,716 | $59,644 | $12,011 | 20.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 161 | 162 | $69,234 | $11,222 | 16.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 25 | $19,837 | $4,218 | 21.3% |
| 93314 | Interpretation and report of ultrasound of heart | Facility | 2022 | 54 | 54 | $21,384 | $3,994 | 18.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 26 | 26 | $19,211 | $3,587 | 18.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 35 | 35 | $14,886 | $3,162 | 21.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $9,123 | $1,846 | 20.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $9,450 | $1,732 | 18.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 13 | 15 | $8,010 | $1,193 | 14.9% |
About Dr. Malissa Wood, MD
Dr. Malissa Wood, MD is a Internal Medicine healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1154312056.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Malissa Wood, MD has received a total of $377,298 in payments from pharmaceutical and medical device companies, with $13,067 received in 2024. These payments were reported across 287 transactions from 18 companies. The most common payment nature is "Consulting Fee" ($289,833).
As a Medicare-enrolled provider, Wood has provided services to 9,719 Medicare beneficiaries, totaling 11,577 services with total Medicare billing of $427,086. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Cardiovascular Disease
- Location Fort Myers, FL
- Active Since 10/31/2005
- Last Updated 08/02/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1154312056
Products in Payments
- TRADJENTA (Drug) $150,250
- Impella (Device) $27,287
- SKYRIZI (Biological) $25,388
- Triage (Device) $21,938
- LUMASON (Drug) $20,398
- RINVOQ (Biological) $19,186
- GLYXAMBI (Drug) $10,500
- GENERAL THERAPIES (Device) $4,010
- MULTAQ (Drug) $2,366
- SONOVUE (Drug) $2,020
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $1,283
- JARDIANCE (Drug) $1,000
- FFRct (Device) $452.95
- SAPIEN 3 Ultra RESILIA (Device) $194.34
- VYNDAQEL (Drug) $105.17
- Mitra Clip system (Device) $99.77
- LifeVest (Device) $95.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fort Myers
Dr. Michael Oleksyk, Md, MD
Internal Medicine — Payments: $570,596
Internal Medicine $570,596
Oliver Abela, Md, MD
Internal Medicine — Payments: $70,958
Internal Medicine $70,958
Francisco De Jesus Paulino, Md, MD
Internal Medicine — Payments: $50,407
Internal Medicine $50,407
Dr. Vinayak Thakur, M.d, M.D
Internal Medicine — Payments: $19,038
Internal Medicine $19,038
Imtiaz Ahmad, Md, MD
Internal Medicine — Payments: $18,331
Internal Medicine $18,331
Ricardo Escarcega Alarcon, M.d, M.D
Internal Medicine — Payments: $17,998
Internal Medicine $17,998